{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T12:44:23Z","timestamp":1655297063104},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00120-022-01835-2","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:10:22Z","timestamp":1653397822000},"page":"587-595","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematisches Handeln\u00a0\u2013 Notf\u00e4lle der medikament\u00f6sen Tumortherapie!"],"prefix":"10.1007","volume":"61","author":[{"given":"Martin","family":"B\u00f6gemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"1835_CR1","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1200\/JCO.2008.20.5534","volume":"27","author":"J Bellmunt","year":"2009","unstructured":"Bellmunt\u00a0J, Theodore\u00a0C, Demkov\u00a0T et al (2009) Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a\u00a0platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J\u00a0Clin Oncol 27:4454\u20134461","journal-title":"J Clin Oncol"},{"key":"1835_CR2","first-page":"3","volume":"34","author":"M Cassagnol","year":"2009","unstructured":"Cassagnol\u00a0M, McBride\u00a0A (2009) Management of chemotherapy extravasations. US Pharm 34:3\u201311","journal-title":"US Pharm"},{"key":"1835_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","volume":"380","author":"K Fizazi","year":"2019","unstructured":"Fizazi\u00a0K, Shore\u00a0N, Tammela\u00a0TL et al (2019) Darolutamide in nonmetastatic, castration-resistant prostate cancer. N\u00a0Engl J Med 380:1235\u20131246","journal-title":"N Engl J Med"},{"key":"1835_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/annonc\/mdr520","volume":"23","author":"S Schelenz","year":"2012","unstructured":"Schelenz\u00a0S, Giles\u00a0D, Abdallah\u00a0S (2012) Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a\u00a0regional UK cancer centre. Ann Oncol 23:1889\u20131893","journal-title":"Ann Oncol"},{"key":"1835_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-31303-6","volume-title":"Kompendium Internistische Onkologie: Standards in Diagnostik und Therapie","author":"HJ Schmoll","year":"2006","unstructured":"Schmoll\u00a0HJ, H\u00f6ffken\u00a0K, Possinger\u00a0K (2006) Kompendium Internistische Onkologie: Standards in Diagnostik und Therapie"},{"key":"1835_CR6","volume-title":"Common terminology criteria for adverse events (CTCAE) v5.0","author":"Department of Health","year":"2017","unstructured":"Department of Health (2017) Common terminology criteria for adverse events (CTCAE) v5.0"},{"key":"1835_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1200\/JOP.18.00016","volume":"14","author":"RA Taplitz","year":"2018","unstructured":"Taplitz\u00a0RA, Kennedy\u00a0EB, Flowers\u00a0CR (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update summary. J\u00a0Oncol Pract 14:250\u2013255","journal-title":"J Oncol Pract"},{"key":"1835_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-60625-4_10","volume-title":"Komplikationen in der Urologie","author":"M B\u00f6gemann","year":"2021","unstructured":"B\u00f6gemann\u00a0M (2021) Medikament\u00f6se Tumortherapie. In: Kranz\u00a0J, Anheuser\u00a0P, Steffens\u00a0JA (Hrsg) Komplikationen in der Urologie. Springer, Berlin, Heidelberg https:\/\/doi.org\/10.1007\/978-3-662-60625-4_10"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-022-01835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-022-01835-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-022-01835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T12:04:41Z","timestamp":1655294681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-022-01835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1007\/s00120-022-01835-2","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"7 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0B\u00f6gemann gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}